Antimicrobial consumption in the EU/EEA (ESAC-Net) - Annual Epidemiological Report for 2020
For 2020, twenty-nine countries (27 European Union (EU) Member States and two European Economic Area (EEA) countries - Iceland and Norway) reported data on antimicrobial consumption. Twenty-five countries reported data for both community and hospital consumption; two countries (Germany and Iceland) reported only community consumption, and two countries (Cyprus and Czechia) reported total consumption for both sectors combined.
Surveillance of antimicrobial resistance in Europe, 2020 data
The results presented in this executive summary are based on antimicrobial resistance (AMR) data from invasive isolates reported to the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) and the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2021 (data referring to 2020). Twelve countries and Kosovo reported data to CAESAR, while 29 countries, including all from the European Union (EU) and two from the European Economic Area (EEA) (Iceland and Norway), reported data to EARS-Net.
Gonococcal antimicrobial susceptibility surveillance in the European Union/European Economic Area, 2019
The surveillance of Neisseria gonorrhoeae antimicrobial susceptibility in the European Union/European Economic Area (EU/EEA) is essential for detecting emerging and increasing antimicrobial resistance. Since 2009, this surveillance has been co-ordinated by the European Centre for Disease Prevention and Control (ECDC). The quality-assured data produced can be used to inform treatment guidelines.
Rapid risk assessment: Increase in OXA-244 -producing Escherichia coli in the European Union/European Economic Area and the UK since 2013, first update
Rapid risk/outbreaks assessment aim at supporting the countries and the European Commission in their preparedness and response to a public health threat. They provide a timely summary and risk assessment of a public health threat for EU/EEA countries related to a specific event. They also include potential options for response. As outbreaks or public health events develop, ECDC may issue updated risk assessments.
JIACRA III - Antimicrobial consumption and resistance in bacteria from humans and animals
Third joint inter-agency report on integrated analysis of antimicrobial agent consumption and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals in the EU/EEA.
Video on hand hygiene - The invisible challenge: in healthcare settings
Video highlighting the importance of hand hygiene in healthcare settings launched ahead of World Hand Hygiene Day 2021.
The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2018/2019
In 2018–2019, data on antimicrobial resistance in zoonotic and indicator bacteria, submitted by 28 EU Member States (MSs), were jointly analysed by the EFSA and the ECDC.
Assessment tool for joint One Health country visits in relation to antimicrobial resistance
This updated assessment tool, which outlines the indicators for human health and the joint parts of the country visits, should be used in conjunction with respective EC assessment tools for the veterinary and environmental sectors. The updated assessment tool was drafted after an expert consultation meeting in Stockholm on 5–6 February 2020 and finalised after review by the participating experts.
Risk Assessment: Emergence of hypervirulent Klebsiella pneumoniae ST23 carrying carbapenemase genes in EU/EEA countries
This document assesses the risk associated with the dissemination of carbapenemase-producing hypervirulent Klebsiella pneumoniae (hvKp) of sequence type (ST) 23 and other STs in the European Union/European Economic Area (EU/EEA).